Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.46 |
| ▸ | CTSB | P07858 | 4/20 | 0.46 |
| ▸ | CTSS | P25774 | 4/20 | 0.46 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8609108 | 1.00 | CTSK (0.46) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL7266856 | 0.84 | ALDH1A1 (0.46) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL7266845 | 0.84 | ALDH1A1 (0.46) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL24049971 | 0.84 | ALDH1A1 (0.50) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL12485024 | 0.84 | ALDH1A1 (0.46) | ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3 | |
| SCHEMBL10831915 | 0.82 | ALDH1A1 (0.51) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL23696190 | 0.82 | ALDH1A1 (0.51) | CTSKCTSBCTSSCTSLALDH1A1 | |
| SCHEMBL8610837 | 0.82 | CTSS (0.47) | CTSBCTSSCTSLALDH1A1MAPK1 | |
| SCHEMBL8610832 | 0.82 | CTSS (0.47) | CTSBCTSSCTSLALDH1A1MAPK1 | |
| SCHEMBL27324113 | 0.81 | ALDH1A1 (0.44) | ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6025286-A | — | — | None | — | — | JP | disclosed |
| EP-0621867-B1 | NEW ENDOTHELIN ANTAGONISTS AND THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-10-07 | — | — | EP | disclosed |
| EP-0457195-B1 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| US-5656604-A | HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| US-5538950-A | PEPTIDE DERIVATIVES AS HYPOTENSIVE AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| US-5430022-A | Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| US-5284828-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1994-02-08 | — | — | US | disclosed |
| JP-H0625286-A | PEPTIDE COMPOUND | FUJISAWA PHARMACEUT CO LTD | 1994-02-01 | — | — | JP | disclosed |
| CN-1057269-A | Peptide compounds and preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1991-12-25 | — | — | CN | disclosed |
| EP-0457195-A2 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-21 | — | — | EP | disclosed |
| JP-H00625286-A | — | — | 0001-01-01 | — | — | JP | disclosed |